NU636 Quiz 2

The document from Advanced Pharmacology discusses a case scenario involving a 51-year-old African American male patient with hypertension. The patient was initially started on chlorthalidone 25mg and advised to follow the DASH diet. However, his blood pressure remained high at 162/108 during his three-month follow-up. The patient's home BP log confirmed consistent high readings. The question posed in the document pertains to the most appropriate addition to his treatment plan, with options including adding Ramipril 2.5 mg, changing from Chlorthalidone to HCTZ, adding Carvedilol 12.5 mg, or adding 5 mg of amlodipine. Additionally, the document addresses the case of a Type 2 diabetic patient with a calculated 10-year risk of cardiac disease and stroke. Despite being averse to taking a statin, the patient agrees to a trial of niacin as part of the pharmacologic treatment plan. This scenario highlights the importance of individualized treatment plans tailored to each patient's unique health needs and preferences.